Evidence map›Paper›PMID 19182229›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2009

Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studies.

Anne R Cappola, Qian-Li Xue, Linda P Fried

Open access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Cortisol and Dehydroepiandrosterone Response to Adrenocorticotropic Hormone and Frailty in Older Women.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anne R CappolaDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Pennsylvania School of Medicine, 415 Curie Blvd, Philadelphia, PA 19104, USA. acappola@mail.med.upenn.edu
Qian-Li Xue
Linda P Fried
Columbia University · USJohns Hopkins University · USUniversity of Pennsylvania · US

Funding

Pathogenesis of physical disability in Aging womenR37AG019905 · NIA · JOHNS HOPKINS UNIVERSITY · PI FRIED, LINDA P · 2001 to 2010
$9.0M
RISK FACTORS FOR PHYSICAL DISABILITY IN AGING WOMENR01AG011703 · NIA · JOHNS HOPKINS UNIVERSITY · PI FRIED, LINDA P · 1994 to 2004
$3.5M
Androgens, Myostatin, and Sarcopenia in Older WomenK23AG019161 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CAPPOLA, ANNE R · 2002 to 2006
$676k
WOMEN'S HEALTH AND AGING-12112N01AG012112 · NIA · JOHNS HOPKINS UNIVERSITY · 1991 to 2003
$500k
NIA NIH HHS K23 AG019161NIA NIH HHS K23 AG 19161NIA NIH HHS N01 AG 12112NIA NIH HHS R01 AG011703NIA NIH HHS R01 AG 11703NIA NIH HHS R37 AG019905NIA NIH HHS R37 AG 19905
6 · The paper itself

Abstract

backgroundAlterations in anabolic hormones are theorized to contribute to aging and frailty, with most studies focusing on the relationship between individual hormones and specific age-associated diseases. We hypothesized that associations with frailty would most likely manifest in the presence of deficits in multiple anabolic hormones.

methodsThe relationships of serum levels of total IGF-1, DHEAS, and free testosterone (T) with frailty status (nonfrail, prefrail, or frail) were analyzed in 494 women aged 70-79 years enrolled in the Women's Health and Aging Studies I or II. Using multivariate polytomous regression, we calculated the odds of frailty for deficiency in each hormone (defined as the bottom quartile of the hormone) individually, as well as for a count of the hormones.

resultsFor each hormone, in adjusted analyses, those with the deficiency were more likely to be frail than those without the deficiency, although this did not achieve statistical significance (IGF-1: odds ratio [OR] 1.82, confidence interval [CI] 0.81-4.08; DHEAS: OR 1.68, CI 0.77-3.69; free T: OR 2.03, CI 0.89-4.64). Compared with those with no hormonal deficiencies, those with one deficiency were not more likely to be frail (OR 1.15, CI 0.49-2.68), whereas those with two or three deficiencies had a very high likelihood of being frail (OR 2.79, CI 1.06-7.32), in adjusted models.

conclusionsThe absolute burden of anabolic hormonal deficiencies is a stronger predictor of frailty status than the type of hormonal deficiency, and the relationship is nonlinear. These analyses suggest generalized endocrine dysfunction in the frailty syndrome.

Indexed as

AgedAge FactorsAgingConfidence IntervalsDehydroepiandrosterone SulfateFemaleFrail ElderlyGeriatric AssessmentHormonesHumansInsulin-Like Growth Factor IMultivariate AnalysisOdds RatioPredictive Value of TestsRisk AssessmentSampling StudiesDehydroepiandrosterone SulfateHormonesInsulin-Like Growth Factor ITestosterone

Identifiers

PMID19182229
PMCPMC2655016
OpenAlexW2145076748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.